tsukiko.kurokawa@metagentx.com (Yamagata, Japan, May 1, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; President & CEO: Taku Nakahara), will have its Chief Scientific Officer Jun Terauchi speaking at The 8th Microbiome R&D and Business Collaboration Congress : Asia on May 7 and 8, 2024 in Singapore.
The event aims to showcase groundbreaking research on microbiome and probiotics, and pledges to provide substantial insights and strategies for researchers and developers in transforming scientific discoveries into viable products.
■Schedule
DAY 2 Wednesday 8th, May
14:30～14:55「FMT Based Microbiome Therapeutics Development in Japan」
JUN TERAUCHI／Chief Scientific Officer, Metagen Therapeutics
For more information, please visit the following website:
■8th Microbiome R&D and Business Collaboration Congress: Asia